Hay fever season in the UK usually begins in late March and runs through to November. However, experts warned back in February the season could begin earlier this year due to the unseasonably mild weather that month causing a rise in pollen. The Met Office said it had noticed levels of pollen already on the rise while the country was still technically in winter. And now we are at the end of March, when pollen rises are normally just beginning to surface, hay fever season is already in full swing.
Allergy Therapeutics (LON:AGY) is an international commercial biotechnology group focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.